We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
98 hedge funds and large institutions have $556M invested in Revance Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 40 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,100% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 3
135% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 17
49% more capital invested
Capital invested by funds: $373M → $556M (+$183M)
48% more funds holding
Funds holding: 66 → 98 (+32)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
98
Holders Change
+32
Holders Change %
+48.48%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
36
Increased
40
Reduced
17
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jennison Associates
New York
|
+$29.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.9M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$13M |
| 4 |
JP Morgan Chase
New York
|
+$12.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$11.7M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$16.8M |
| 2 |
ZDA
Zweig-DiMenna Associates
New York
|
-$6.41M |
| 3 |
Millennium Management
New York
|
-$6.29M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$4.67M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.66M |
